---
schema_version: "secwatch.filing_event.v1"
accession: "0001517022-25-000010"
form_type: "8-K"
ticker: "AKBA"
cik: "0001517022"
company_name: "Akebia Therapeutics, Inc."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:54:04.289038+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Akebia draws $9.3M net from extended loan tranche; issues warrant for 1.15M shares

## Summary
- Extended Tranche C expiry from Dec 31, 2024 to Feb 3, 2025; interest accrues from Dec 31, 2024.
- Drew $10M Tranche C on Feb 3, 2025; net proceeds of $9.3M after debt issuance costs and interest.
- Issued warrant to Kreos Capital affiliate for 1,153,846 shares at $1.30 exercise, 8-year term.
- Warrant not registered; relies on Section 4(a)(2) and Rule 506(b) exemption.
- Loan facility total $55M; prior tranches of $37M and $8M already drawn.

## SEC filing metadata
- accession: 0001517022-25-000010
- form_type: 8-K
- ticker: AKBA
- cik: 0001517022
- company_name: Akebia Therapeutics, Inc.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517022/000151702225000010/0001517022-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517022/000151702225000010/akba-20250203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001517022-25-000010
- JSON: https://secwatch.observer/filing/0001517022-25-000010.json
- Plain text: https://secwatch.observer/filing/0001517022-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.